Tesnatilimab Uses, Dosage, Side Effects and more
Tesnatilimab is under investigation in clinical trial NCT04655807 (A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease).
| Trade Name | Tesnatilimab |
| Generic | Tesnatilimab |
| Tesnatilimab Other Names | Tesnatilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
